Identa Corp
IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company … Read more
Identa Corp (IDTA) - Net Assets
Latest net assets as of June 2025: $747.08K USD
Based on the latest financial reports, Identa Corp (IDTA) has net assets worth $747.08K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.69 Million) and total liabilities ($940.08K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $747.08K |
| % of Total Assets | 44.28% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 8.2 |
Identa Corp - Net Assets Trend (2002–2023)
This chart illustrates how Identa Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Identa Corp (2002–2023)
The table below shows the annual net assets of Identa Corp from 2002 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $516.12K | +12.29% |
| 2022-12-31 | $459.63K | +6.89% |
| 2021-12-31 | $430.01K | +26.34% |
| 2020-12-31 | $340.37K | +2118.92% |
| 2019-12-31 | $-16.86K | -0.80% |
| 2018-12-31 | $-16.73K | +89.71% |
| 2017-12-31 | $-162.56K | -9558.65% |
| 2016-12-31 | $-1.68K | +99.57% |
| 2015-12-31 | $-391.30K | -318.32% |
| 2014-12-31 | $-93.54K | +92.96% |
| 2011-12-31 | $-1.33 Million | -16.04% |
| 2010-12-31 | $-1.15 Million | +20.00% |
| 2003-12-31 | $-1.43 Million | +5.70% |
| 2002-12-31 | $-1.52 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Identa Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7484200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $4.00 Million | 775.94% |
| Total Equity | $516.12K | 100.00% |
Identa Corp Competitors by Market Cap
The table below lists competitors of Identa Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XSLR
F:XSLR
|
$1.01 Million |
|
EVIO Inc
PINK:EVIO
|
$1.01 Million |
|
VOGO S.A. EO-125
F:7CY
|
$1.01 Million |
|
CWTH BK AUSTRALIA
MU:CWW
|
$1.01 Million |
|
Wirecard AG
PINK:WRCDF
|
$1.01 Million |
|
RangDong Plastic JSC
VN:RDP
|
$1.01 Million |
|
Biovaxys Technology Corp
OTCQB:BVAXF
|
$1.01 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
$1.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Identa Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 459,629 to 516,116, a change of 56,487 (12.3%).
- Net income of 14,644 contributed positively to equity growth.
- Other factors increased equity by 41,843.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $14.64K | +2.84% |
| Other Changes | $41.84K | +8.11% |
| Total Change | $- | 12.29% |
Book Value vs Market Value Analysis
This analysis compares Identa Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $0.00 | $0.55 | x |
| 2003-12-31 | $0.00 | $0.55 | x |
| 2010-12-31 | $0.00 | $0.55 | x |
| 2011-12-31 | $0.00 | $0.55 | x |
| 2017-12-31 | $-0.04 | $0.55 | x |
| 2018-12-31 | $0.00 | $0.55 | x |
| 2019-12-31 | $0.00 | $0.55 | x |
| 2020-12-31 | $0.08 | $0.55 | x |
| 2021-12-31 | $0.11 | $0.55 | x |
| 2022-12-31 | $0.11 | $0.55 | x |
| 2023-12-31 | $0.13 | $0.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Identa Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.39%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 2.96x
- Recent ROE (2.84%) is below the historical average (11.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -307.13% | 0.17x | 0.00x | $-74.14K |
| 2003 | 0.00% | 40.49% | 0.04x | 0.00x | $148.66K |
| 2010 | 0.00% | -165.86% | 0.50x | 0.00x | $-101.96K |
| 2011 | 0.00% | -86.14% | 0.58x | 0.00x | $-57.06K |
| 2014 | 0.00% | -149.56% | 0.61x | 0.00x | $-632.37K |
| 2015 | 0.00% | -68.39% | 1.31x | 0.00x | $-450.92K |
| 2016 | 0.00% | -109.23% | 0.74x | 0.00x | $-450.35K |
| 2017 | 0.00% | -41.31% | 0.93x | 0.00x | $-155.28K |
| 2018 | 0.00% | 17.28% | 1.44x | 0.00x | $144.53K |
| 2019 | 0.00% | 6.47% | 1.49x | 0.00x | $67.20K |
| 2020 | 104.14% | 24.45% | 1.37x | 3.12x | $320.41K |
| 2021 | 16.09% | 4.97% | 1.13x | 2.86x | $26.18K |
| 2022 | 35.40% | 12.15% | 0.82x | 3.53x | $116.75K |
| 2023 | 2.84% | 1.39% | 0.69x | 2.96x | $-36.97K |
Industry Comparison
This section compares Identa Corp's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Identa Corp (IDTA) | $747.08K | 0.00% | 1.26x | $1.01 Million |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |